Cerebrovascular flow‐mediated dilation in humans: Methodological challenges, physiological interpretation and future integrations
Experimental Physiology · 2026-11 · 111 (11) · 5061-5073
DOI: 10.1113/ep093070 ↗At a glance
Übersichtsarbeit in Experimental Physiology, published online on 2026-06-22. Written by Yi Zhen Bao and 4 co-authors. Institution: Department of Human Health Sciences, Integrative Cerebrovascular and Environmental Physiology SB Laboratory, University of Guelph, Guelph, Ontario, C…. Major MEDLINE topics: Vasodilation, Cerebrovascular Circulation. Cited 2 times so far (Crossref); 68 references. The full text is freely available (open access, CC BY 4.0). Funded by: NSERC Discovery Grant, Brain Canada Grant.
Abstract (original language)
Arterial shear‐mediated vasodilation is a well‐established measure of endothelial function and serves as a critical biomarker for cardiovascular disease risk. Endothelial function can be measured using a variety of experimental methodologies; however, the most widely adopted technique is ultrasound‐based flow‐mediated dilation (FMD), in which arterial diameter (e.g., brachial or femoral artery) is quantified before and after a standardized period of blood occlusion using a pressure cuff. Recently, there have been several published studies that have assessed cerebrovascular flow‐mediated dilation (cFMD) in the internal carotid artery (ICA) using transient and steady‐state hypercapnia. Hypercapnia increases cerebral blood flow (CBF), and the consequent increase in arterial shear stress provokes ICA vasodilation. The ICA diameter response is mediated by endothelial derived nitric oxide, like the peripheral vasculature. Since the introduction of the cFMD technique, there have been several early studies investigating the effects of exercise, environment, autonomic nervous activity, age, sex and vasoactive hormones on cerebral endothelial function. While some findings parallel existing literature on peripheral endothelial function or studies primarily measuring shear stress (e.g. effects of ageing), others reveal unique aspects of cFMD regulation that diverge from trends seen in other techniques (e.g., smoking, sitting and handgrip exercise). This review aims to synthesize early findings on the mechanism(s) underlying cFMD, compare methodological approaches, and outline future research directions and potential clinical applications in this emerging field.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Human Health Sciences, Integrative Cerebrovascular and Environmental Physiology SB Laboratory, University of Guelph, Guelph, Ontario, Canada.
- School of Exercise Science, Physical and Health Education, Cerebrovascular Hemodynamics, Exercise, and Environmental Research Sciences (CHEERS) Laboratory, University of Victoria, Victoria, British Columbia, Canada.
ORCID profiles: Tabitha V Craig, Jenna C McCrone, Kurt J Smith, Michael M Tymko
Funding
- NSERC Discovery Grant
- Brain Canada Grant
Cite
APA
Bao, Y. Z., Craig, T. V., McCrone, J. C., Smith, K. J., & Tymko, M. M. (2026). Cerebrovascular flow‐mediated dilation in humans: Methodological challenges, physiological interpretation and future integrations. Experimental Physiology, 111(11), 5061-5073. https://doi.org/10.1113/ep093070
Vancouver
Bao YZ, Craig TV, McCrone JC, Smith KJ, Tymko MM. Cerebrovascular flow‐mediated dilation in humans: Methodological challenges, physiological interpretation and future integrations. Experimental Physiology. 2026;111(11):5061-5073. doi:10.1113/ep093070
BibTeX
@article{Bao2026,
author = {Bao, Yi Zhen and Craig, Tabitha V and McCrone, Jenna C and Smith, Kurt J and Tymko, Michael M},
title = {Cerebrovascular flow‐mediated dilation in humans: Methodological challenges, physiological interpretation and future integrations},
journal = {Experimental Physiology},
year = {2026},
volume = {111},
number = {11},
pages = {5061--5073},
doi = {10.1113/ep093070}
}
EUVIMED